Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer. - Raizenne BL; Koshkin VS; Zhu A; Ben-David R; Dufault SM; Eraky A; Friedlander TW; Hong JC; Wong AC; Chou J; Chu C; Mar N; et al. (Clinical genitourinary cancer, 2026)